HOME >> BIOLOGY >> NEWS
Rett Syndrome traced to defective gene 'silencer'

September 30, 1999-- A 14-year search for the cause of a rare genetic disease that strikes young girls has uncovered the first example of a human disease linked to a defect in a mechanism designed to keep certain genes silent. This discovery may provide new insights into nervous system development in the fetus and young child.

Rett syndrome (RTT) is a neurodevelopmental disorder seen in young girls that causes a sudden and permanent decline in mental capabilities. In 1985, HHMI investigator Huda Zoghbi, who was then a neurology fellow, published a clinical research report on Rett syndrome. Her initial encounter with the disorder had a lasting impact on her career. Shortly after seeing her first RTT patients, Zoghbi decided to change her career plans, switching from clinical medicine to a research position. Shortly after switching to research, she started the long, tedious search for the genetic causes of RTT.

"Finding that gene is the hardest thing I've ever worked on," Zoghbi said in an interview. "It's the best case for the rewards of perseverance that I can think of."

The gene, called MECP2, resides on the far end of the longest arm of the X chromosome. MECP2 encodes a protein named methyl-CpG-binding protein 2, or MeCP2, that binds to genes that a cell has methylated. During development certain genes that are to be silenced, or prevented from being expressed, are physically marked by the addition of methyl groups. When bound to a methylated gene, MeCP2 facilitates gene silencing by attracting other proteins that prevent access to the cell's DNA transcription machinery.

Previous work by other researchers had shown that inactivating the mouse version of Mecp2 caused a lethal defect in male mouse embryos. Zoghbi's group at Baylor College of Medicine, in collaboration with researchers led by

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
1-Oct-1999


Page: 1 2 3 4

Related biology news :

1. Introduction of the Rett protein in post-mitotic neurons rescues Rett Syndrome in mice
2. Researchers discover novel form of the Rett Syndrome protein
3. Study offers new insight into Rett Syndrome
4. RSRF-funded study leads to breakthrough for Rett Syndrome research
5. The Rett Syndrome Research Foundation commits $1.3 million for 2003 research awards
6. Folic acid may have no immediate impact on Down Syndrome
7. A derivative of the green tea leaf may help with Metabolic Syndrome X, a potentially deadly disorder
8. Researchers find a genetic connection in Sudden Infant Death Syndrome (SIDS)
9. CDC MMWR: Fetal Alcohol Syndrome and Cutaneous Anthrax in a Lab Worker
10. Scientists create first animal model of Rett Syndrome
11. Gene for DiGeorge Syndrome discovered

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/1/2020)... (PRWEB) , ... April 30, 2020 , ... ... emerging infectious diseases, announced today that it had been awarded a contract from ... the Assistant Secretary for Preparedness and Response at the U.S. Department of Health ...
(Date:4/30/2020)... (PRWEB) , ... April 29, 2020 , ... ... well positioned for continued growth – delivering innovative solutions for a wide range ... chemical, aerospace and government agencies. A month into the new decade, it was ...
(Date:4/23/2020)... ... April 23, 2020 , ... Despite the current COVID-19 ... infrastructure products for the animal feed, human consumption, wastewater, and biotech sectors, and ... supply channels from overseas competitors have become weakened or shut down completely, new ...
Breaking Biology News(10 mins):
(Date:4/22/2020)... ... April 20, 2020 , ... ... Cambridge, MA, announced today that Omixon’s founder and chairman Dr. Attila Berces returns ... flagship product Holotype HLA since 2014 before stepping into the CEO role in ...
(Date:4/18/2020)... ... 17, 2020 , ... NeuroFlow has been awarded ... to support the expansion of its digital health platform enabling behavioral health integration ... merit-based review process, adds to NeuroFlow’s recent government awards . , The ...
(Date:4/1/2020)... , ... March 30, 2020 , ... ... its latest product, ArmourGuard® RTU, an EPA-approved spray-on antimicrobial solution. As a first-of-its-kind ... solution that provides continual antimicrobial activity against microorganisms for up to 90 days. ...
(Date:4/1/2020)... JOLLA, Calif. (PRWEB) , ... March 31, 2020 , ... ... Jolla Institute for Immunology (LJI), announced today that they will use Carterra’s proprietary LSA™ ... move therapeutic candidates to the clinic as early as this summer. , La ...
Breaking Biology Technology:
Cached News: